Medical technology company InMode (NASDAQ: INMD) has announced preliminary earnings results for the third quarter 2020 saying that based on initial results it expects record revenues in the range of $59.2 to $59.5 million.
InMode also said that its earnings per diluted share for the third quarter will be in the range of $0.60 to $0.62 while it has increased its full-year revenue guidance for 2020 to between $192 to $195 million.
It’s two leading electro-surgical proprietary technologies, invasive and hands-free “are becoming the gold standard of the minimally invasive surgical procedures,” said Moshe Mizrahy, InMode’s CEO.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
“We expect the underlying interest in our differentiated product suite will continue to drive sales into the fourth quarter of 2020. As a result, we decided to increase our full year 2020 revenue guidance to $192-$195 million,” commented Mizrahy.
InMode’s share price has jumped 21% since the release to $47.50 after closing Monday at $39.13. Its stock has gained 56% in the last six months.
PEOPLE WHO READ THIS ALSO VIEWED:
- Gossamer Bio stock plummets, here’s why…
- Trade stocks with Plus500
- Learn stock trading strategies